Author:
Malec M,Björklund E,Söderhäll S,Mazur J,Sjögren A-M,Pisa P,Björkholm M,Porwit-MacDonald A
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference40 articles.
1. Campana D, Pui CH . Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance Blood 1995 85: 1416–1434
2. Orfao A, Ciudad J, Lopez-Berges MC, Lopez A, Vidriales B, Caballero MD, Valverde B, Gonzalez M, San Miguel JF . Acute lymphoblastic leukemia (ALL): detection of minimal residual disease (MRD) at flow cytometry Leuk Lymphoma 1994 13: (Suppl. 1) 87–90
3. van Dongen JJ, Szczepanski T, de Bruijn MA, van den Beemed MW, de Bruin-Versteeg S, Wijkhuijs JM, Tibbe GJ, van Gastel-Mol EJ, Groeneveld K, Hooijkaas H . Detection of minimal residual disease in acute leukemia patients Cytokines Mol Ther 1996 2: 121–133
4. Jacquy C, Delepaut B, Van Daele S, Vaerman JL, Zenebergh A, Brichard B, Vermylen C, Cornu G, Martiat P . A prospective study of minimal residual disease in childhood B-lineage acute lymphoblastic leukaemia: MRD level at the end of induction is a strong predictive factor of relapse Br J Haematol 1997 98: 140–146
5. Gruhn B, Hongeng S, Yi H, Hancock ML, Rubnitz JE, Neale GA, Kitchingman GR . Minimal residual disease after intensive induction therapy in childhood acute lymphoblastic leukemia predicts outcome Leukemia 1998 12: 675–681
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献